Results 251 to 260 of about 1,389,478 (387)

Process and outcome evaluation of a regional pulmonary embolism response team. [PDF]

Thromb J
Weekes AJ, Cerpa FC, Goonan KL, Polzella AL, Hogg MM, Cox D, Flannigan S, Cruz E, O'Neill HA, O'Connell NS, Troha DR.   +10 more
europepmc   +1 more source

Plication of the Inferior Vena Cava for Pulmonary Embolism*

, 1962
Frank C. Spencer, Julian K. Quattlebaum, Julian K. Quattlebaum, Edward H. Sharp, James R. Jude   +4 more
openalex   +2 more sources

Pulmonary angiography with external cardiac compression in fatal pulmonary embolism. [PDF]

, 1968
Himleena Gautam
openalex   +1 more source

Venous thromboembolism related to cytomegalovirus infection: A case report and literature review [PDF]

, 2017
Farrell, John J, Jacob, Kavitha S, Kelkar, Amar H, Yousif, Eman B   +3 more
core   +2 more sources

Effects of immune checkpoint inhibitors on the pulmonary circulation in lung cancer patients

International Journal of Cancer, EarlyView.
What's New? Immune checkpoint inhibitors (ICIs) are effective against various cancers, but as more patients receive these therapies, more immune‐related adverse events (irAEs) emerge. Recent studies have suggested that ICIs are associated with an increase in pulmonary artery diameter and the ratio between pulmonary artery diameter and aortic diameter ...
Yao Xu, Qiuhong Zhang, Jie Gao, Shiyuan Yao, Chan Tian, Tuo He, Ming Zhang, Hu Shan, Jie Shi, Bo Yuan, Lei Wang, Xia Yang   +11 more
wiley   +1 more source

Electrocardiographic Prediction of Acute Pulmonary Embolism at Intermediate-High- and High-Risk. [PDF]

Circ Rep
Nakayama H, Komatsu J, Nishimura Y, Sugane H, Hosoda H, Imai RI, Nakaoka Y, Nishida K, Mito S, Seki SI, Kubo T, Yamasaki N, Kitaoka H, Kubokawa SI, Kawai K, Hamashige N, Doi Y.   +16 more
europepmc   +1 more source

Effect of Lung Denervation on Pulmonary Embolism [PDF]

, 1966
Walter H. Massion
openalex   +1 more source

A Dramatic Presentation of Pulmonary Edema Due to Renal Failure [PDF]

, 2020
Farha, Natalie, Munguti, Cyrus
core   +2 more sources

Transcatheter tricuspid valve replacement using the LuX‐Valve Plus system: 1‐year compassionate use outcomes

European Journal of Heart Failure, EarlyView.
Lukas Stolz, Neil Fam, Geraldine Ong, Pedro Villablanca, Ahmad Jabri, Ole de Backer, Jacob Eifer Mølller, Didier Tchétché, Omar Oliva, Kent Chak‐Yu So, Yat‐Yin Lam, Azeem Latib, Andrea Scotti, Augustin Coisne, Arnaud Sudre, Julien Dreyfus, Mohammed Nejjari, Ignacio Cruz‐Gonzalez, Rodrigo Estévez‐Loureiro, Manuel Barreiro‐Perez, Guillaume Leurent, Erwan Donal, Guillaume Bonnet, Thomas Modine, Raj Makkar, Dhairya Patel, Karl‐Patrik Kresoja, Philipp Lurz, Jörg Hausleiter   +28 more
wiley   +1 more source

Olaparib for patients with tumors harboring alterations in homologous recombination repair genes: Results from the drug rediscovery protocol

International Journal of Cancer, EarlyView.
What's New? PARP inhibitors are effective in patients with inactivating alterations in the BRCA1/2 genes across tumor types. However, the efficacy of PARP inhibitors in patients with other inactivated homologous recombination repair genes remains unclear. This knowledge gap and discrepancies in EMA/FDA approvals highlight the need for better biomarkers.
Ilse A. C. Spiekman, Niven Mehra, Laurien J. Zeverijn, Birgit S. Geurts, Karlijn Verkerk, Soemeya F. Haj Mohammad, Vincent van der Noort, Paul Roepman, Wendy W. J. de Leng, Anne M. L. Jansen, Addy C. M. van de Luijtgaarden, Theo van Voorthuizen, Tineke E. Buffart, Hans Gelderblom, Emile E. Voest, Henk M. W. Verheul   +15 more
wiley   +1 more source